UMDF’s Mitochondrial Medicine Symposium

JW Marriott Phoenix Desert Ridge Resort & Spa Phoenix, AZ, United States

Abliva will participate at the United Mitochondrial Disease Foundation's Mitochondrial Medicine Symposium in Phoenix, Arizona. Abliva's CMO, Magnus Hansson, will participate in a panel discussion on clinical trials together with Baylor College of Medicine, Cyclerion Therapeutics, and Khondrion, on Friday June 10.

Fireside Chat in Lund

Restaurang Inspira Scheeletorget 1, Lund, Sweden

In light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about the path forward directly from Ellen Donnelly (CEO) and the Abliva team. We hope you will join us in Lund during the Midsummer week to […]

Fireside Chat in Stockholm

Erik Penser Bank Apelbergsgatan 27, Stockholm, Sweden

In light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about the path forward directly from Ellen Donnelly (CEO) and the Abliva team. We hope you will join us in Stockholm during the Midsummer week to […]

Bioblast 2022: Inaugural Conference of Bioenergetics Communications

Congress Innsbruck Rennweg 3, Innsbruck, Austria

On June 29-30, Abliva will participate at Bioblast 2022: Inaugural Conference of Bioenergetics Communications in Innsbruck, Austria. Abliva's Communications Officer & Lab Manager, Eleonor Åsander Frostner, will present a summary of the company's recent preprint publication "Towards a treatment for mitochondrial disease: current compounds in clinical development".

Aktiespararna’s Digital Temadag – Life Science

Virtual

Abliva will be attending Aktiespararna's Digital Temadag - Life Science, on Aug 31, 2022. CEO Ellen Donnelly will present the company at 6:20 p.m. CEST. Follow link below for further information.

mitoNice

Nice Acropolis Congress Center Nice, France

In September, Abliva will attend mitoNice, an international congress dedicated to Mitochondrial Medicine.

Aktiedagen Lund

Elite Hotel Ideon Scheelevägen 27, Lund, Sweden

On September 26 (Monday), 2022, Abliva will attend Aktiespararna's Aktiedagen Lund, at Elite Hotel Ideon. CEO Ellen Donnelly will present the company at 4 p.m. CEST. See below for more info and registration.

Nordic Life Science Days 2022

Malmömässan Mässgatan 6, Malmö, Sweden

Abliva will attend the Nordic Life Science Days in Malmö, Sweden, on September 28-29, 2022. CEO Ellen Donnelly will be presenting the company at 11:00 CEST on Sep 29.

Mitocon’s Mitochondrial Diseases Conference

Holiday Inn Rome EUR Parco dei Medici Rome, Italy

In October, Abliva will attend the Italian patient organization Mitocon's annual Mitochondrial Diseases Conference in Rome, Italy. On October 8, Abliva's Chief Medical Officer Magnus Hansson will give the talk: An adaptive, clinical Phase 2/3 study evaluating the efficacy of KL1333 in adult primary mitochondrial disease patients in Session 5: Challenges and pitfalls in clinical […]

Shareholders’ meeting in Olofström

Olofström , Sweden

Abliva will visit Aktiespararna Västra Blekinge/Bromölla in Olofström on November 8, 2022. Abliva's CFO Catharina Johansson and Communications Officer Eleonor Åsander Frostner will be presenting the company during the evening. See below for more info and registration.

Shareholders’ meeting in Tommarp

Tommarps bygdegård Storgatan 52, Tommarp, Sweden

Abliva will come to Aktiespararna's local club Sydöstra Skåne, in Tommarp, Sweden, on November 17, 2022. Abliva’s CFO Catharina Johansson and Communications Officer Eleonor Åsander Frostner will be presenting the company during the evening. See below for more info and registration.